On the contrary, other studies revealed that enhancing macrophage autophagy by the mTOR inhibitor may be a viable therapeutic or preventative approach to inflammatory disease, obesity insulin resistance, and diabetes [44, 53]. Here, MTOR is linked to obesity due to melanocortin 4 receptor deficiency.